Viridian Therapeutics

VRDN · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Previous year: -$0.79

+10.1%

Weighted-average common shares outstanding

81.34M

Previous year: 61.1M

+33.1%

Research and development expenses

$76.8M

Previous year: $40.9M

+87.7%

General and administrative expenses

Loading...

Viridian Therapeutics

Unlock previous datapoints

Upgrade

Viridian Therapeutics

Unlock previous datapoints

Upgrade

Viridian Therapeutics Revenue by Segment

Revenue by Segment

Collaboration Revenue - related party Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$1.89B

P/E Ratio

-4.81

Sector

N/A

Industry

N/A

52-Week High

$33.7

52-Week Low

$11

Weighted-average common shares outstanding

81.34M

Research and development expenses

$76.8M

General and administrative expenses

$17.1M

Total operating expenses

$93.9M

Interest and other income

$7.54M

Products

Get in Touch

Resources

Viridian Therapeutics

Viridian Therapeutics

Viridian Therapeutics

Viridian Therapeutics Revenue by Segment

Revenue by Segment

Collaboration Revenue - related party Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics